부산대학교 도서관

In Urologic Oncology: Seminars and Original Investigations May 2014 32(4):512-513

In Urologic Oncology: Seminars and Original Investigations January 2013 31(1):127-128

In Urologic Oncology: Seminars and Original Investigations September-October 2012 30(5):746-747

In Urologic Oncology: Seminars and Original Investigations 2011 29(5):585-586

Laskar, RS; Muller, DC; Li, P; Machiela, MJ; Ye, YQ; Gaborieau, V; Foll, M; Hofmann, JN; Colli, L; Sampson, JN; Wang, ZM; Bacq-Daian, D; Boland, A; Abedi-Ardekani, B; Durand, G; Le Calvez-Kelm, F; Robinot, N; Blanche, H; Prokhortchouk, E; Skryabin, KG; Burdett, L; Yeager, M; Radojevic-Skodric, S; Savic, S; Foretova, L; Holcatova, I; Janout, V; Mates, D; Rascu, S; Mukeria, A; Zaridze, D; Bencko, V; Cybulski, C; Fabianova, E; Jinga, V; Lissowska, J; Lubinski, J; Navratilova, M; Rudnai, P; Swiatkowska, B; Benhamou, S; Cancel-Tassin, G; Cussenot, O; Trichopoulou, A; Riboli, E; Overvad, K; Panico, S; Ljungberg, B; Sitaram, RT; Giles, GG; Milne, RL; Severi, G; Bruinsma, F; Fletcher, T; Koppova, K; Larsson, SC; Wolk, A; Banks, RE; Selby, PJ; Easton, DF; Pharoah, P; Andreotti, G; Freeman, LEB; Koutros, S; Albanes, D; Mannisto, S; Weinstein, S; Clark, PE; Edwards, TL; Lipworth, L; Carol, H; Freedman, ML; Pomerantz, MM; Cho, E; Kraft, P; Preston, MA; Wilson, KM; Gaziano, JM; Sesso, HD; Black, A; Freedman, ND; Huang, WY; Anema, JG; Kahnoski, RJ; Lane, BR; Noyes, SL; Petillo, D; Teh, B; Peters, U; White, E; Anderson, GL; Johnson, L; Luo, JH; Chow, WH; Moore, LE; Choueiri, TK; Wood, C; Johansson, M; McKay, JD; Brown, KM; Rothman, N; Lathrop, MG; Deleuze, JF; Wu, XF; Brennan, P; Chanock, SJ; Purdue, MP; Scelo, G

European journal of human genetics : EJHG. 27(10):1589-1598

In Urologic Oncology: Seminars and Original Investigations 2011 29(5):583-584

In Urologic Oncology: Seminars and Original Investigations 2011 29(1):114-114

Machiela, MJ; Jonathan, NHA; Carreras-Torres, R; Brown, KM; Johansson, M; Wang, ZM; Foll, M; Li, P; Rothman, N; Savage, SA; Gaborieau, V; Mckay, JD; Ye, YQ; Henrion, M; Bruinsma, F; Jordan, S; Severi, G; Hveem, K; Vatten, LJ; Fletcher, T; Koppova, K; Larsson, SC; Wolk, A; Banks, RE; Selby, PJ; Easton, DF; Pharoah, P; Andreotti, G; Freeman, LEB; Koutros, S; Albanes, D; Mannisto, S; Weinstein, S; Clark, PE; Edwards, TE; Lipworth, L; Gapstur, SM; Stevens, VL; Carol, H; Freedman, ML; Pomerantz, MM; Cho, E; Kraft, P; Preston, MA; Wilson, KM; Gaziano, JM; Sesso, HSi; Black, A; Freedman, ND; Huang, WY; Anema, JG; Kahnoski, RJ; Lane, BR; Noyes, SL; Petillo, D; Colli, LM; Sampson, JN; Besse, C; Blanche, H; Boland, A; Burdette, L; Prokhortchouk, E; Skryabin, KG; Yeager, M; Mijuskovic, M; Ognjanovic, M; Foretova, L; Holcatova, I; Janout, V; Mates, D; Mukeriya, A; Rascu, S; Zaridze, D; Bencko, V; Cybulski, C; Fabianova, E; Jinga, V; Lissowska, J; Lubinski, J; Navratilova, M; Rudnai, P; Szeszenia-Dabrowska, N; Benhamou, S; Cancel-Tassin, G; Cussenot, O; Bueno-De-Mesquita, HB; Canzian, F; Duell, EJ; Ljungberg, B; Sitaram, RT; Peters, U; White, E; Anderson, GL; Johnson, L; Luo, J; Buring, J; Lee, IM; Chow, WH; Moore, LE; Wood, C; Eisen, T; Larkin, J; Choueiri, TK; Lathrop, GM; Teh, BT; Deleuze, JF; Wu, X; Houlstonmmm, RS; Brennan, P; Chanock, SJ; Scelo, G; Purdue, MP

European urology. 72(5):747-754

Grivas, P; Khaki, AR; Wise-Draper, TM; French, B; Hennessy, C; Hsu, C-Y; Shyr, Y; Li, X; Choueiri, TK; Painter, CA; Peters, S; Rini, BI; Thompson, MA; Mishra, S; Rivera, DR; Acoba, JD; Abidi, MZ; Bakouny, Z; Bashir, B; Bekaii-Saab, T; Berg, S; Bernicker, EH; Bilen, MA; Bindal, P; Bishnoi, R; Bouganim, N; Bowles, DW; Cabal, A; Caimi, PF; Chism, DD; Crowell, J; Curran, C; Desai, A; Dixon, B; Doroshow, DB; Durbin, EB; Elkrief, A; Farmakiotis, D; Fazio, A; Fecher, LA; Flora, DB; Friese, CR; Fu, J; Gadgeel, SM; Galsky, MD; Gill, DM; Glover, MJ; Goyal, S; Grover, P; Gulati, S; Gupta, S; Halabi, S; Halfdanarson, TR; Halmos, B; Hausrath, DJ; Hawley, JE; Hsu, E; Huynh-Le, M; Hwang, C; Jani, C; Jayaraj, A; Johnson, DB; Kasi, A; Khan, H; Koshkin, VS; Kuderer, NM; Kwon, DH; Lammers, PE; Li, A; Loaiza-Bonilla, A; Low, CA; Lustberg, MB; Lyman, GH; McKay, RR; McNair, C; Menon, H; Mesa, RA; Mico, V; Mundt, D; Nagaraj, G; Nakasone, ES; Nakayama, J; Nizam, A; Nock, NL; Park, C; Patel, JM; Patel, KG; Peddi, P; Pennell, NA; Piper-Vallillo, AJ; Puc, M; Ravindranathan, D; Reeves, ME; Reuben, DY; Rosenstein, L; Rosovsky, RP; Rubinstein, SM; Salazar, M; Schmidt, AL; Schwartz, GK

Annals of Oncology. 32(6)

Rossi SH; Department of Surgery, University of Cambridge, Cambridge, UK; Cancer Research UK Cambridge Centre, Cambridge Biomedical Campus, Cambridge, UK.; Choueiri TK; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, USA.; Jewett M; Department of Surgery and Surgical Oncology (Urology), Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Canada; International Kidney Cancer Coalition, Utrecht, The Netherlands.; Jones JO; Cancer Research UK Cambridge Centre, Cambridge Biomedical Campus, Cambridge, UK; Department of Oncology, University of Cambridge, Cambridge, UK; Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, UK.; Laird A; Department of Urology, Western General Hospital, Edinburgh, UK; Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh, UK.; Lewis B; KidneyCAN, Philadelphia, USA.; Tippu Z; Francis Crick Institute, London, UK.; Van Der Mijn JCK; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Bex A; Division of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Division of Surgery and Interventional Science, Royal Free London NHS Foundation Trust, University College London, London, UK.; Stewart GD; Department of Surgery, University of Cambridge, Cambridge, UK; Cancer Research UK Cambridge Centre, Cambridge Biomedical Campus, Cambridge, UK. Electronic address: gds35@cam.ac.uk.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Jay, Raman; McKay, RR; Werner, L; Atkins, MB; Van Allen, EM; Olivier, KM; Song, J; Signoretti, S; McDermott, DF; Choueiri, TK

In Urologic Oncology: Seminars and Original Investigations March 2017 35(3):117-118

Fradet, Y; Bellmunt, J; Vaughn, DJ; Lee, JL; Fong, L; Vogelzang, NJ; Climent, MA; Petrylak, DP; Choueiri, TK; Necchi, A; Gerritsen, W; Gurney, H; Quinn, DI; Culine, S; Sternberg, CN; Nam, K; Frenkl, TL; Perini, RF; de Wit, R; Bajorin, DF

Annals of Oncology. 30(6)

Semaan K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Nawfal R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Canniff J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Savignano H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Seo JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Siegmund SE; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Wu SJ; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Rotow JK; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Lee GM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; El Hajj Chehade R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA.; Zhang Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA.; Gulati GS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Phillips N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Lee GG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA.; French CA; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Hirsch MS; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Jacene HA; Department of Imaging, Dana-Farber Cancer Institute, Boston, MA, USA.; Choudhury AD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Freedman ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA.; Baca SC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. sylvan_baca@dfci.harvard.edu.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA. sylvan_baca@dfci.harvard.edu.; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA. sylvan_baca@dfci.harvard.edu.; Berchuck JE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. jberchuck@emory.edu.; Winship Cancer Institute of Emory University, Atlanta, GA, USA. jberchuck@emory.edu.; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA. jberchuck@emory.edu.

Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE

Steiner C; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.; Machaalani M; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.; Bonventre JV; Harvard Medical School, Boston, MA, USA; Brigham and Women's Hospital, Boston, MA, USA.; McDermott DF; Harvard Medical School, Boston, MA, USA; Beth Israel Deaconess Medical Center, Boston, MA, USA.; Choueiri TK; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.; Xu W; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: wenxin_xu1@dfci.harvard.edu.

Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101665661 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2405-4569 (Electronic) Linking ISSN: 24054569 NLM ISO Abbreviation: Eur Urol Focus Subsets: MEDLINE

Labaki C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.; Center of Molecular and Cellular Oncology (CMCO), Yale School of Medicine, New Haven, CT.; Saad E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Center of Molecular and Cellular Oncology (CMCO), Yale School of Medicine, New Haven, CT.; Madsen KN; Center of Molecular and Cellular Oncology (CMCO), Yale School of Medicine, New Haven, CT.; Hobeika C; Department of Medicine, Cleveland Clinic Fairview Hospital, Cleveland, OH.; Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Bi K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Alchoueiry M; Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Camp S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Hou Y; Akoya Biosciences Inc, Marlborough, MA.; Bakouny Z; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.; Matar S; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; El Ahmar N; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Nyman J; PathAI, Inc, Boston, MA.; Zhang L; University of Shanghai for Science and Technology, Shanghai, China.; Priolo C; Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Rout R; Center of Molecular and Cellular Oncology (CMCO), Yale School of Medicine, New Haven, CT.; Daou M; Department of Medicine, Yale University, New Haven, CT.; Khabibullin D; Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Salem S; Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Schindler N; Center of Molecular and Cellular Oncology (CMCO), Yale School of Medicine, New Haven, CT.; Saliby RM; Center of Molecular and Cellular Oncology (CMCO), Yale School of Medicine, New Haven, CT.; Department of Medicine, Yale University, New Haven, CT.; Meli K; RBC Capital Markets, New York, NY.; Wells JC; BC Cancer Agency, Vancouver, Canada.; Pimenta E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Takemura K; Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada.; Park J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Eid M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Semaan K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Fu J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Denize T; Department of Pathology, Massachusetts General Hospital, Boston, MA.; El Hajj Chehade R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Machaalani M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Nawfal R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Khatoun WD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Saleh M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; El Masri J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Haddad NR; Johns Hopkins University School of Medicine, Baltimore, MD.; Xu W; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; McGregor BA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Hirsch MS; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Xie W; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Heng DYC; Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada.; McDermott DF; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.; Signoretti S; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Shukla SA; Department of Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Texas, Houston, TX.; Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Henske EP; Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Braun DA; Center of Molecular and Cellular Oncology (CMCO), Yale School of Medicine, New Haven, CT.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Mizuno K; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Ku SY; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Venkadakrishnan VB; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Bakht MK; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Sigouros M; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA.; Chan J; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Trigos A; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; St. Vincent's Institute of Medical Research, Fitzroy, VIC, Australia.; Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC, Australia.; Driskill JH; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.; Manohar J; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA.; King A; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA.; Presser AG; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Kim MJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Tewari AK; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Long HW; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Quigley D; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.; Department of Urology, University of California San Francisco, San Francisco, CA, USA.; Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Balk S; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Hill S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Mosquera JM; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA.; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.; Einstein D; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Sandhu S; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Taplin ME; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Beltran H; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. himisha_beltran@dfci.harvard.edu.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Roy AM; Ohio State Comprehensive Cancer Center, Columbus, OH.; Bakouny Z; Memorial Sloan Kettering Cancer Center, New York, NY.; Dizman N; The University of Texas MD Anderson Cancer Center, Houston, TX.; Paul MA; Dana-Farber Cancer Institute, Boston, MA.; Ozay ZI; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT.; Lal BM; University of Arkansas for Medical Sciences, Little Rock, AR.; Nawfal R; Dana-Farber Cancer Institute, Boston, MA.; Eid M; Dana-Farber Cancer Institute, Boston, MA.; Chehade REH; Dana-Farber Cancer Institute, Boston, MA.; Machaalani M; Dana-Farber Cancer Institute, Boston, MA.; Butt A; Yale University, New Haven, CT.; Aggarwal C; Perelman School of Medicine at the University of Pennsylvania, Abramson Cancer Center, Philadelphia, PA.; Bekaii-Saab T; Mayo Clinic Comprehensive Cancer Center, Phoenix, AZ.; Chavez-MacGregor M; The University of Texas MD Anderson Cancer Center, Houston, TX.; Lopes G; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.; Marshall AL; University of Minnesota, Minneapolis, MN.; Murphy M; University of Florida, Gainesville, FL.; Owonikoko T; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Xie W; Dana-Farber Cancer Institute, Boston, MA.; Lee AI; Yale University, New Haven, CT.; Choueiri TK; Dana-Farber Cancer Institute, Boston, MA.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101758685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2688-1535 (Electronic) Linking ISSN: 26881527 NLM ISO Abbreviation: JCO Oncol Pract Subsets: MEDLINE

Machiela, MJ; Hofmann, JN; Carreras-Torres, R; Brown, KM; Johansson, M; Wang, Z; Foll, M; Li, P; Rothman, N; Savage, SA; Gaborieau, V; Mckay, JD; Ye, YQ; Henrion, M; Bruinsma, F; Jordan, S; Severi, G; Hveem, K; Vatten, LJ; Fletcher, T; Koppova, K; Larsson, SC; Wolk, A; Banks, RE; Selby, PJ; Easton, DF; Pharoah, P; Andreotti, G; Freeman, LEB; Koutros, S; Albanes, D; Mannisto, S; Weinstein, S; Clark, PE; Edwards, TE; Lipworth, L; Gapstur, SM; Stevens, VL; Carol, H; Freedman, ML; Pomerantz, MM; Cho, E; Kraft, P; Preston, MA; Wilson, KM; Gaziano, JM; Sesso, HS; Black, A; Freedman, ND; Huang, WY; Anema, JG; Kahnoski, RJ; Lane, BR; Noyes, SL; Petillo, D; Colli, LM; Sampson, JN; Besse, C; Blanche, H; Boland, A; Burdette, L; Prokhortchouk, E; Skryabin, KG; Yeager, M; Mijuskovic, M; Ognjanovic, M; Foretova, L; Holcatova, I; Janout, V; Mates, D; Mukeriya, A; Rascu, S; Zaridze, D; Bencko, V; Cybulski, C; Fabianova, E; Jinga, V; Lissowska, J; Lubinski, J; Navratilova, M; Rudnai, P; Szeszenia-Dabrowska, N; Benhamou, S; Cancel-Tassin, G; Cussenot, O; Bueno-De-Mesquita, HBA; Canzian, F; Duell, EJ; Ljungberg, B; Sitaram, RT; Peters, U; White, E; Anderson, GL; Johnson, L; Luo, J; Buring, J; Lee, IM; Chow, WH; Moore, LE; Wood, C; Eisen, T; Larkin, J; Choueiri, TK; Lathrop, GM; Teh, BT; Deleuze, JF; Wu, X; Houlston, RS; Brennan, P; Chanock, SJ; Scelo, G; Purdue, MP

European urology. 74(3):E84-E85

Park SH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.; Chang YH; Department of Urology, Taipei Veterans General Hospital, Taipei, Taiwan.; Lee JL; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.; Choueiri TK; Department of Medical Oncology, Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute, Boston, MA, USA.; Kimura G; Department of Urology, Nippon Medical School Hospital, Tokyo, Japan.; Chung J; Department of Urology, National Cancer Center, Goyang, Korea.; Masumori N; Department of Urology, Sapporo Medical University Hospital, Sapporo, Japan.; Nishimura K; Department of Urology, Osaka International Cancer Institute, Osaka, Japan.; Kato M; Department of Urology, Osaka Metropolitan University Hospital, Osaka, Japan.; Kato H; Department of Urology, Nagano Municipal Hospital, Nagano, Japan.; Numakura K; Department of Urology, Akita University Graduate School of Medicine, Akita, Japan.; Chang CH; Department of Urology, China Medical University Hospital, Taichung, Taiwan.; Anai S; Nara Prefecture Seiwa Medical Center, Nara, Japan.; Department of Urology, Nara Medical University, Nara, Japan.; Tsunemori H; Takinomiya General Hospital, Ayagawa, Japan.; Department of Urology, Kagawa University Hospital, Miki, Japan.; Chen CH; Department of Urology, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan.; Lin J; Merck & Co., Inc., Rahway, NJ, USA.; Elfiky A; Merck & Co., Inc., Rahway, NJ, USA.; Burgents JE; Merck & Co., Inc., Rahway, NJ, USA.; Kitamura H; Department of Urology, University of Toyama, Toyama, Japan.

Publisher: Korean Cancer Association Country of Publication: Korea (South) NLM ID: 101155137 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2005-9256 (Electronic) Linking ISSN: 15982998 NLM ISO Abbreviation: Cancer Res Treat Subsets: MEDLINE

Yekedüz E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Department of Medical Oncology, Ankara University Faculty of Medicine, Ankara, Türkiye.; Zarba M; Department of Medical Oncology, Arthur J.E. Child Comprehensive Cancer Centre, University of Calgary, Calgary, Alberta, Canada.; Saad E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Chehade REH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Eid M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Saliby RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Department of Internal Medicine, Yale School of Medicine, New Haven, CT.; Steiner C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Machaalani M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Nawfal R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Semaan K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Ürün Y; Department of Medical Oncology, Ankara University Faculty of Medicine, Ankara, Türkiye.; Heng DYC; Department of Medical Oncology, Arthur J.E. Child Comprehensive Cancer Centre, University of Calgary, Calgary, Alberta, Canada.; Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. Electronic address: toni_choueiri@dfci.harvard.edu.

Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE